LAST PRICE - AT THE CLOSE
DRUG is UP 138% since the begininning of the year
DRUG is UP 23% ABOVE 20 day SMA
DRUG is UP 106% ABOVE 200 day SMA
PROFITABLE: NO
EPS: $-0.536582
EARNINGS MOMENTUM: YES
0.14% INCREASE IN QTRLY EARNINGS
P/E RATIO IS: N/A
INCOME TO DEBT RATIO: 0.00
 |
THE STOCK IS 8.3% AWAY FROM ALL-TIME HIGHS OF $93.4 |
 |
DRUG IS UP 138% SINCE THE BEGINNING OF THE YEAR |
 |
DRUG IS UP 109% OVER THE PAST 12 MONTHS |
 |
DRUG IS UP 46% OVER THE PAST 1 MONTH |
 |
6% OF ALL DRUG INVESTORS ARE BETTING AGAINST DRUG |
 |
NUM INVESTORS SHORT DRUG HAS GONE UP N/A% VERSUS LAST MONTH |
| Type | Description | Time |
|---|---|---|
 | New premarket high. ... | 12/15 |
 | New premarket low. ... | 12/15 |
 | Up 4% for the day. | 12/15 |
 | Crossed above VWAP | 12/15 |
 | Crossed below VWAP | 12/15 |
 |
DRUG moved down 0.41 in the previous minute |
 |
DRUG is up 0.35 over the last hour |
 |
DRUG is up 6.6% over the last 5 days |
 |
DRUG is 6.7 above its 8 day SMA |
| $84.85 |   DAY |
$88.00 |
| $81.91 | PREVIOUS DAY |
$93.40 |
| $75.07 |  WEEK |
$93.40 |
| $55.01 | MONTH |
$93.40 |
| $0.94 | YEAR |
$93.40 |
DRUG is mentioned N/A less than normal on 
DRUG is mentioned N/A times in an average day on 
